Patient Safety, Support & Advocacy

At Celgene, we take special care to provide patients safe access to our treatments. We have developed unique, industry-leading programs under which hundreds of thousands of patients worldwide have accessed the clinical benefits of our therapies.

Patient Safety

Celgene has been a leader in effective safety surveillance systems as a component of its broader risk management programs. The safety of the patients we serve is of paramount importance. Our products are marketed and distributed with thorough labeling and product information. Celgene develops labeling and informational material in compliance with regulatory bodies such as the US Food and Drug Administration (FDA) and the European Medicines Agency.

Learn More

LFECPS

Research & Development

Celgene invests significant resources into the research and development of disease altering therapies for cancer and other serious immune-inflammatory conditions.

Learn More

Innovation Impact Awards

Celgene’s Award program is a natural outgrowth of our company’s commitment to innovation at every level by honoring patient and professional organizations that have shown excellence in crafting novel solutions that creatively meet patient, caregiver and/or healthcare providers’ needs.

Learn More

Celgene European Patient Group Support

Across Europe, Celgene provides support to organizations and initiatives that make a positive impact on our patients, our communities and our world, today and for years to come. We are committed to improving the lives of patients and focus our support in areas where we can make the greatest impact.

Learn More

EFPIA Spend Transparency Disclosure

As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Celgene supports and complies fully with the EFPIA Disclosure Code for payments made to healthcare providers (HCPs) and Healthcare Organizations (HCOs).

Learn More